University Hospitals Is First in Cleveland To Offer GT Medical Technologies' New Targeted Therapy for Brain Tumors GammaTile® Therapy Is Shown To Slow Brain Tumor Progression, Designed To Improve Patient and Caregiver Quality of Life News provided by Share this article Share this article CLEVELAND, Feb. 17, 2021 /PRNewswire/ -- A University Hospitals Cleveland Medical Center neurosurgeon is among the first in the region to begin offering GammaTile ® Therapy, a new approach to treating brain tumors. GammaTile Therapy is an FDA-cleared, Surgically Targeted Radiation Therapy (STaRT) that is de...